136 related articles for article (PubMed ID: 16227408)
1. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo.
Zhang SZ; Pan FY; Xu JF; Yuan J; Guo SY; Dai G; Xue B; Shen WG; Wen CJ; Zhao DH; Li CJ
Mol Cancer Ther; 2005 Oct; 4(10):1577-84. PubMed ID: 16227408
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.
Li X; Pan Y; Fan R; Jin H; Han S; Liu J; Wu K; Fan D
Carcinogenesis; 2008 Aug; 29(8):1587-93. PubMed ID: 18299278
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
4. [Effects of c-met-siRNA on the growth and invasion of hepatocellular carcinoma MHCC97-H cells].
Xie B; Tang DG; Dong JH
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):499-504. PubMed ID: 16867270
[TBL] [Abstract][Full Text] [Related]
5. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
6. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
Steinway SN; Dang H; You H; Rountree CB; Ding W
PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702
[TBL] [Abstract][Full Text] [Related]
7. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.
You H; Ding W; Dang H; Jiang Y; Rountree CB
Hepatology; 2011 Sep; 54(3):879-89. PubMed ID: 21618573
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.
Chen J; Yang L; Chen H; Yuan T; Liu M; Chen P
Exp Mol Pathol; 2014 Apr; 96(2):207-11. PubMed ID: 24440736
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
10. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
11. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
[TBL] [Abstract][Full Text] [Related]
12. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
14. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
15. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
[TBL] [Abstract][Full Text] [Related]
16. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
17. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction.
Yang YM; Lee CG; Koo JH; Kim TH; Lee JM; An J; Kim KM; Kim SG
Oncotarget; 2015 Aug; 6(22):19055-69. PubMed ID: 25965999
[TBL] [Abstract][Full Text] [Related]
18. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of the metastasis-associated factors of a new human hepatocellular carcinoma cell line with highly metastatic potential].
Tian J; Tang Z; Xue Q
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):470-2. PubMed ID: 11715447
[TBL] [Abstract][Full Text] [Related]
20. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
